Skip Navigation


Carcinogenesis Advance Access originally published online on May 9, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/7/1159    most recent
bgg067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zoumpourlis, V.
Right arrow Articles by Papaevangeliou, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoumpourlis, V.
Right arrow Articles by Papaevangeliou, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 7, 1159-1165, July 2003
© 2003 Oxford University Press

REVIEW

Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis

Vassilis Zoumpourlis1, Sylvia Solakidi, Alexandra Papathoma and Dimitra Papaevangeliou

Laboratory of Gene Regulation, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, 48 Vas Constantinou Avenue, 11635 Athens, Greece

1 To whom correspondence should be addressed. Tel: +30 210 7273745; Fax: +30 210 7273677; Email: vzub{at}eie.gr

The multistage mouse skin carcinogenesis model, although an artificial one, is an ideal system to study the timing of qualitative and quantitative alterations which take place during the different stages of chemical carcinogenesis, allowing analysis of the events that lead to the transition from the stage of initiation to the stage of promotion and finally to the progression of carcinogenesis. In this review we focus on the role of the H-ras gene and its target molecules during mouse skin carcinogenesis. Besides H-ras, which is a critical target of chemical carcinogens, we report alterations in oncosuppressor genes. Finally, we examine the potential suppression of metastatic dynamics of spindle cells after biological or chemical inhibition of the signalling cascades involved in mouse skin carcinogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
M. Liontos, M. Koutsami, M. Sideridou, K. Evangelou, D. Kletsas, B. Levy, A. Kotsinas, O. Nahum, V. Zoumpourlis, M. Kouloukoussa, et al.
Deregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior
Cancer Res., November 15, 2007; 67(22): 10899 - 10909.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Ouyang, Y. Hu, J. Li, M. Ding, Y. Lu, D. Zhang, Y. Yan, L. Song, Q. Qu, D. Desai, et al.
Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells
Carcinogenesis, October 1, 2007; 28(10): 2218 - 2226.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Y. Chung, J. H. Park, M. J. Kim, H. O. Kim, J. K. Hwang, S. K. Lee, and K. K. Park
Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-{kappa}B
Carcinogenesis, June 1, 2007; 28(6): 1224 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ruiz, M. Santos, M. F. Lara, C. Segrelles, C. Ballestin, and J. M. Paramio
Unexpected Roles for pRb in Mouse Skin Carcinogenesis
Cancer Res., November 1, 2005; 65(21): 9678 - 9686.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Marwaha, Y.-H. Chen, E. Helms, S. Arad, H. Inoue, E. Bord, R. Kishore, R. D. Sarkissian, B. A. Gilchrest, and D. A. Goukassian
T-oligo Treatment Decreases Constitutive and UVB-induced COX-2 Levels through p53- and NF{kappa}B-dependent Repression of the COX-2 Promoter
J. Biol. Chem., September 16, 2005; 280(37): 32379 - 32388.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Papassava, V. G. Gorgoulis, D. Papaevangeliou, S. Vlahopoulos, H. van Dam, and V. Zoumpourlis
Overexpression of Activating Transcription Factor-2 Is Required for Tumor Growth and Progression in Mouse Skin Tumors
Cancer Res., December 1, 2004; 64(23): 8573 - 8584.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.